1) Pathology of residual cases
残留病例病理
3) Residue
[英]['rezɪdju:] [美]['rɛzə'du]
病灶残留
1.
Detection of Residue of Nasopharyngeal Carcinoma with FDG PET;
FDG PET判断鼻咽癌放疗后鼻咽病灶残留的临床价值
4) MRD
微小残留病
1.
Detection of MRD and Its Clinical Application —— Review;
微小残留病检测方法及其临床应用
2.
The minimal residual disease (MRD) in 19 patients with chronic myelogenous leukemia (CML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) was detected by DD-FISH, and the detected results were compared with those of conventional cytogenetics (CC) and reverse transcription-polymerase chain reaction (RT-PCR).
对19例慢性髓细胞白血病(CML)异基因造血干细胞移植(allo-HSCT)后微小残留病灶(MRD)用DD-FISH进行监测,同时与常规细胞遗传学(CC)、逆转录-聚合酶链反应(RT-PCR)结果相比较。
5) Minimal residual disease
微小残留病
1.
Progress in study on minimal residual disease of childhood acute leukemia;
儿童急性白血病微小残留病的研究进展
2.
Detection of minimal residual disease with acute promyelocytic leukemia in complete remission by flow cytometry and the reverse transcription polymerase chain reaction;
流式细胞术和RT-PCR检测APL完全缓解患者微小残留病
3.
The existence of leukemia aberrant immunophenotypes (LAIP) has been suggested to be a valuable tool for the detection of minimal residual disease (MRD), as they could distinguish leukemic cells from normal hematopoietic progenitors.
白血病细胞异常免疫表型是区别于正常造血细胞的重要特征之一,也是流式细胞术检测微小残留病的基础。
6) Minimal residual disease
微量残留病
1.
Minimal residual disease was traced successfully in 44 cases by polymerase chain reaction using TCR δ and IgH rearrangement genes as markers.
目的 探讨小儿急性淋巴细胞白血病 (ALL)微量残留病 (MRD)检测的临床意义 ,进一步了解ALL复发与缓解的生物学特点。
2.
This study was aimed to explore prognostic significance of minimal residual disease (MRD) detection in patients with acute myeloid leukemia (AML) by multiparameter flow cytometry (MCF).
本研究探讨多参数流式细胞术检测急性髓系白血病(AML)微量残留病(MRD)的方法和预后意义。
3.
ObjectiveMinimal residual disease(MRD) is one of the most important prognostic factors in childhood acute lymphoblastic leukemia(ALL).
目的微量残留病(MRD)监测是儿童急性淋巴细胞白血病(ALL)早期治疗反应中最重要的预后因素之一。
补充资料：病例对照调查
见环境流行病学。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条